Dorda, working with McDermott Will & Emery and Quinz, has successfully advised P95 on its acquisition of the Austrian CRO Assign DMB.
P95 is an epidemiological and clinical solutions company. According to Dorda, it is "further expanding its global footprint with this acquisition. Assign DMB, renowned for its expertise in clinical data management and biostatistics, particularly in infectious diseases and vaccines, is a perfect complement to P95's service portfolio."
The Dorda team included Partner Lukas Herrmann, Senior Associate Georg Durstberger, and Associate Bianca Schamberger.
Dorda did not respond to our inquiry on the matter.
